These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18478051)
1. The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis. El-Tahtawy A; Glue P; Andrews EN; Mardekian J; Amsden GW; Knirsch CA PLoS Negl Trop Dis; 2008 May; 2(5):e236. PubMed ID: 18478051 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers. Amsden GW; Gregory TB; Michalak CA; Glue P; Knirsch CA Am J Trop Med Hyg; 2007 Jun; 76(6):1153-7. PubMed ID: 17556628 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review. McPherson S; Solomon AW; Seife F; Solomon H; Gebre T; Mabey DCW; Marks M PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011224. PubMed ID: 37315102 [TBL] [Abstract][Full Text] [Related]
4. Investigation of pharmacokinetic interaction between ivermectin and praziquantel after oral administration in healthy dogs. Ozdemir Z; Faki HE; Uney K; Tras B J Vet Pharmacol Ther; 2019 Sep; 42(5):497-504. PubMed ID: 31183888 [TBL] [Abstract][Full Text] [Related]
5. The Repurposing of Ivermectin for Malaria: A Prospective Pharmacokinetics-Based Virtual Clinical Trials Assessment of Dosing Regimen Options. Badhan R; Zakaria Z; Olafuyi O J Pharm Sci; 2018 Aug; 107(8):2236-2250. PubMed ID: 29626533 [TBL] [Abstract][Full Text] [Related]
6. Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. Na-Bangchang K; Kietinun S; Pawa KK; Hanpitakpong W; Na-Bangchang C; Lazdins J Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):335-45. PubMed ID: 16271272 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers. Duthaler U; Suenderhauf C; Karlsson MO; Hussner J; Meyer Zu Schwabedissen H; Krähenbühl S; Hammann F Br J Clin Pharmacol; 2019 Mar; 85(3):626-633. PubMed ID: 30566757 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep. Canga AG; Sahagun A; Diez MJ; Fernandez N; Sierra M; Garcia JJ Am J Vet Res; 2007 Jan; 68(1):101-6. PubMed ID: 17199426 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ivermectin in sheep following pretreatment with Escherichia coli endotoxin. Riquelme J; Cazanga V; Jeldres J; Pérez R J Vet Pharmacol Ther; 2018 Oct; 41(5):755-759. PubMed ID: 29889311 [TBL] [Abstract][Full Text] [Related]
10. A review of the pharmacological interactions of ivermectin in several animal species. González-Canga A; Fernández-Martínez N; Sahagún-Prieto A; Diez-Liébana MJ; Sierra-Vega M; García-Vieitez JJ Curr Drug Metab; 2009 May; 10(4):359-68. PubMed ID: 19519344 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep. Pérez R; Palma C; Núñez MJ; Cox J J Vet Pharmacol Ther; 2008 Oct; 31(5):406-14. PubMed ID: 19000259 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs. Dunn ST; Hedges L; Sampson KE; Lai Y; Mahabir S; Balogh L; Locuson CW Drug Metab Dispos; 2011 May; 39(5):789-95. PubMed ID: 21321059 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep. Pérez R; Palma C; Núñez MJ; Cox J; Arboix M J Vet Pharmacol Ther; 2008 Feb; 31(1):71-6. PubMed ID: 18177322 [TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics and Exposure-Response Analysis of a Fixed-Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults. Algorta J; Kepha S; Krolewiecki A; Li H; Giang J; Fleitas P; Mwandawiro C; Muñoz J; Clin Pharmacol Ther; 2024 Sep; ():. PubMed ID: 39308346 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of orally administered ivermectin in African elephants (Loxodonta africana): implications for parasite elimination. Gandolf AR; Lifschitz A; Stadler C; Watson B; Galvanek L; Ballent M; Lanusse C J Zoo Wildl Med; 2009 Mar; 40(1):107-12. PubMed ID: 19368248 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs. Eraslan G; Kanbur M; Liman BC; Cam Y; Karabacak M; Altinordulu S Food Chem Toxicol; 2010; 48(8-9):2181-5. PubMed ID: 20488222 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2-12 years. Schulz JD; Coulibaly JT; Schindler C; Wimmersberger D; Keiser J J Antimicrob Chemother; 2019 Jun; 74(6):1642-1647. PubMed ID: 30859185 [TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Awadzi K; Hero M; Opoku NO; Büttner DW; Coventry PA; Prime MA; Orme ML; Edwards G Trop Med Parasitol; 1994 Sep; 45(3):203-8. PubMed ID: 7899788 [TBL] [Abstract][Full Text] [Related]
19. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466 [TBL] [Abstract][Full Text] [Related]
20. The effect of breed, sex, and drug concentration on the pharmacokinetic profile of ivermectin in cattle. Gotardo AT; Fonseca RL; Barreto F; Tomaszewski CA; Barnet LS; Castilho T; Górniak SL J Vet Pharmacol Ther; 2020 Sep; 43(5):477-484. PubMed ID: 32270537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]